Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Nationwide salpingectomy rates for an indication of permanent contraception before and after published practice guidelines.

Polen-De C, Meganathan K, Lang P, Hohmann S, Jackson A, Whiteside JL.

Contraception. 2019 Aug;100(2):111-115. doi: 10.1016/j.contraception.2019.03.054. Epub 2019 Apr 30.

PMID:
31051117
2.

The Trend, Feasibility, and Safety of Salpingectomy as a form of Permanent Sterilization.

Kim AJ, Barberio A, Berens P, Chen HY, Gants S, Swilinski L, Acholonu U, Chang-Jackson SC.

J Minim Invasive Gynecol. 2019 Feb 13. pii: S1553-4650(19)30089-5. doi: 10.1016/j.jmig.2019.02.003. [Epub ahead of print]

PMID:
30771489
3.

Women's preferences for permanent contraception method and willingness to be randomized for a hypothetical trial.

Piazza A, Schwirian K, Scott F, Wilson MD, Zite NB, Creinin MD.

Contraception. 2019 Jan;99(1):56-60. doi: 10.1016/j.contraception.2018.09.004. Epub 2018 Sep 26.

PMID:
30266212
4.

The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.

Hanley GE, McAlpine JN, Pearce CL, Miller D.

Am J Obstet Gynecol. 2017 Mar;216(3):270.e1-270.e9. doi: 10.1016/j.ajog.2016.10.035. Epub 2016 Nov 1.

PMID:
27810554
5.

Opportunistic salpingectomy during postpartum contraception procedures at elective and unscheduled cesarean delivery.

Ferrari F, Forte S, Prefumo F, Sartori E, Odicino F.

Contraception. 2019 Jun;99(6):373-376. doi: 10.1016/j.contraception.2019.03.041. Epub 2019 Mar 18.

PMID:
30898658
6.

Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.

Dilley SE, Havrilesky LJ, Bakkum-Gamez J, Cohn DE, Michael Straughn J Jr, Caughey AB, Rodriguez MI.

Gynecol Oncol. 2017 Aug;146(2):373-379. doi: 10.1016/j.ygyno.2017.05.034. Epub 2017 Jun 1.

PMID:
28577884
7.

Successful completion of total and partial salpingectomy at the time of cesarean delivery.

Lehn K, Gu L, Creinin MD, Chen MJ.

Contraception. 2018 Sep;98(3):232-236. doi: 10.1016/j.contraception.2018.06.003. Epub 2018 Jun 20.

8.

ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.

[No authors listed]

Obstet Gynecol. 2019 Apr;133(4):842-843. doi: 10.1097/AOG.0000000000003165.

PMID:
30913193
9.

No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.

Salvador S, Scott S, Francis JA, Agrawal A, Giede C.

J Obstet Gynaecol Can. 2017 Jun;39(6):480-493. doi: 10.1016/j.jogc.2016.12.005.

PMID:
28527613
10.

Salpingectomy for Sterilization: Change in Practice in a Large Integrated Health Care System, 2011-2016.

Powell CB, Alabaster A, Simmons S, Garcia C, Martin M, McBride-Allen S, Littell RD.

Obstet Gynecol. 2017 Nov;130(5):961-967. doi: 10.1097/AOG.0000000000002312.

PMID:
29016486
11.

Hospital Variation in the Practice of Bilateral Salpingectomy With Ovarian Conservation in 2012.

Xu X, Desai VB.

Obstet Gynecol. 2016 Feb;127(2):297-305. doi: 10.1097/AOG.0000000000001203.

PMID:
26942357
12.

Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.

Hanley GE, Kwon JS, Finlayson SJ, Huntsman DG, Miller D, McAlpine JN.

Am J Obstet Gynecol. 2018 Aug;219(2):172.e1-172.e8. doi: 10.1016/j.ajog.2018.05.019. Epub 2018 May 28.

PMID:
29852159
13.

Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.

Cadish LA, Shepherd JP, Barber EL, Ridgeway B.

Am J Obstet Gynecol. 2017 Nov;217(5):603.e1-603.e6. doi: 10.1016/j.ajog.2017.06.007. Epub 2017 Jun 12.

PMID:
28619689
14.

Uptake and Utilization of Practice Guidelines in Hospitals in the United States: the Case of Routine Episiotomy.

Kozhimannil KB, Karaca-Mandic P, Blauer-Peterson CJ, Shah NT, Snowden JM.

Jt Comm J Qual Patient Saf. 2017 Jan;43(1):41-48. doi: 10.1016/j.jcjq.2016.10.002. Epub 2016 Oct 13.

PMID:
28334585
15.

Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.

Mikami M, Nagase S, Yamagami W, Ushijma K, Tashiro H, Katabuchi H; Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology (JSOG).

J Gynecol Oncol. 2017 Jul;28(4):e52. doi: 10.3802/jgo.2017.28.e52.

16.

The Use of Opportunistic Salpingectomy at the Time of Benign Hysterectomy.

Till SR, Kobernik EK, Kamdar NS, Edwards MG, As-Sanie S, Campbell DA, Morgan DM.

J Minim Invasive Gynecol. 2018 Jan;25(1):53-61. doi: 10.1016/j.jmig.2017.07.004. Epub 2017 Jul 13.

PMID:
28712794
17.

Success and Complications of Salpingectomy at the Time of Vaginal Hysterectomy.

Robert M, Cenaiko D, Sepandj J, Iwanicki S.

J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):864-9. doi: 10.1016/j.jmig.2015.04.012. Epub 2015 Apr 22.

PMID:
25911271
18.

Safety outcomes of female sterilization by salpingectomy and tubal occlusion.

Westberg J, Scott F, Creinin MD.

Contraception. 2017 May;95(5):505-508. doi: 10.1016/j.contraception.2017.02.017. Epub 2017 Feb 21.

19.

Adnexectomy at the time of vaginal hysterectomy for pelvic organ prolapse.

Slopnick EA, Sheyn DD, Chapman GC, Mahajan ST, El-Nashar S, Hijaz AK.

Int Urogynecol J. 2019 May 21. doi: 10.1007/s00192-019-03967-0. [Epub ahead of print]

PMID:
31115610
20.

Hysterectomies in Portugal (2000-2014): What has changed?

Gante I, Medeiros-Borges C, Águas F.

Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:97-102. doi: 10.1016/j.ejogrb.2016.11.021. Epub 2016 Nov 21.

Supplemental Content

Support Center